2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC
Titel:
2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC
Auteur:
Lu, S. Fang, J. Li, X. Cao, L. Zhou, J. Guo, Q. Liang, Z. Cheng, Y. Jiang, L. Yang, N. Han, Z. Shi, J. Chen, Y. Xu, H. Zhang, H. Chen, G. Ma, R. Sun, S. Fan, Y. Weiguo, S.